Groundbreaking discovery! Prostrate cancer development linked to Five “Mutants.”
Let us meet LEPR, CRY1, RNASEL, IL4, and ARVCF! Researchers have identified these five new gene variants, or mutations that
Read moreProstate Cancer
Abbott’s Lupron, a long-acting treatment for premature puberty, received FDA approval
On Tuesday, Abbott Laboratories announced that two longer-acting doses of Lupron, a treatment for premature puberty, have been approved by
Read moreTargeted Radiation allows for Safer Prostate Cancer Treatment
The first multi-institutional study to assess a new form of radiation treatment for prostate cancer along with sophisticated real-time tumor
Read more